Dany Gholam

Advanced seminoma—Treatment results and prognostic factors for survival after first‐line, cisplatin‐based chemotherapy and for patients with recurrent disease

Dany Gholam, Karim Fizazi, Marie‐Jose Terrier‐Lacombe et al. · Cancer · 2003 · 64 citations · Full text

Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study

F. Rétornaz, Olivier Guillem, Frédérique Rousseau et al. · The Oncologist · 2019 · 51 citations · Full text

A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody

Dany Gholam, J Vantelon, Ahmad Aljijakli et al. · Annals of Hematology · 2003 · 39 citations

Alzheimer's Disease, Autoimmune Disease, Immunology +6

Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer

Dany Gholam, Sylvie Giacchetti, Catherine Brezault‐Bonnet et al. · The Oncologist · 2006 · 36 citations · Full text

Combined paclitaxel and cetuximab achieved a major response on the skin metastases of a patient with epidermal growth factor receptor-positive, estrogen receptor-negative, progesterone receptor-negative and human epidermal growth factor receptor-2-negative (triple-negative) breast cancer

Dany Gholam, Amale Chebib, D Hauteville et al. · Anti-Cancer Drugs · 2007 · 32 citations

Skin Metastases, Epidermal Growth Factor, Breast Oncology +14